Maxion Therapeutics

Maxiom Therapeutics is a biotechnology company headquartered in Cambridge, UK, dedicated to the development of biopharmaceuticals. Maxiom Therapeutics has developed biologics targeting ion channels and GPCRs, which are key cell surface proteins involved in a wide range of previously untreatable or poorly treated diseases, including autoimmune disorders and chronic pain. The company is applying its proprietary KnotBody technology to generate potent, selective, and long-acting antibody-like target modulators.